The Glycaemic Effect of Isomaltulose Consumption in Healthy Participants
1 other identifier
interventional
46
0 countries
N/A
Brief Summary
The objective of this study is to determine the glycaemic effect of isomaltulose and sucrose in Chinese, Indian, Malay, and Caucasian individuals. The current study will provide important information on the potential health benefits of isomaltulose consumption in Asian population. It will also reveal how the three main ethnicities in Singapore respond to isomaltulose and whether the response differs from the Caucasians.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable diabetes-mellitus
Started Dec 2014
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2016
CompletedFirst Submitted
Initial submission to the registry
January 10, 2017
CompletedFirst Posted
Study publicly available on registry
January 13, 2017
CompletedJanuary 13, 2017
January 1, 2017
1.8 years
January 10, 2017
January 11, 2017
Conditions
Outcome Measures
Primary Outcomes (1)
Change in post prandial Blood glucose for 180 minutes period
Blood glucose obtained through finger pricks using Hemocue Glucose Analyser
180 minutes
Study Arms (2)
Isomaltulose
EXPERIMENTAL50g of isomaltulose dissolved in 250ml of water
Sucrose
EXPERIMENTAL50g of sucrose dissolved in 250ml of water
Interventions
Isomaltulose is a disaccharide made up of one molecule glucose and fructose with a (α1-6) linkage.
Eligibility Criteria
You may qualify if:
- Chinese, Indian, Malay or Caucasian ethnic origin
You may not qualify if:
- People with major chronic disease such as heart disease, cancer or diabetes mellitus
- Individuals with food intolerances or allergies to isomaltulose or sucrose
- Individuals who are taking insulin or drugs known to affect glucose metabolism and body fat distribution
- People with a major medical or surgical event requiring hospitalization within the preceding 3 months
- Individuals with the presence of disease or drugs which influence digestion and absorption of nutrients
- Pregnant women
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Melvin Leow, MD
Clinical Nutrition Research Centre
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
January 10, 2017
First Posted
January 13, 2017
Study Start
December 1, 2014
Primary Completion
September 1, 2016
Study Completion
September 1, 2016
Last Updated
January 13, 2017
Record last verified: 2017-01
Data Sharing
- IPD Sharing
- Will not share